CN102002036B - 一种法舒地尔的精制方法 - Google Patents
一种法舒地尔的精制方法 Download PDFInfo
- Publication number
- CN102002036B CN102002036B CN 200910184597 CN200910184597A CN102002036B CN 102002036 B CN102002036 B CN 102002036B CN 200910184597 CN200910184597 CN 200910184597 CN 200910184597 A CN200910184597 A CN 200910184597A CN 102002036 B CN102002036 B CN 102002036B
- Authority
- CN
- China
- Prior art keywords
- fasudil
- purification
- ethyl acetate
- temperature
- normal hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- NGOGFTYYXHNFQH-UHFFFAOYSA-N fasudil Chemical compound C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 NGOGFTYYXHNFQH-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229960002435 fasudil Drugs 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 37
- 238000007670 refining Methods 0.000 title abstract description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 93
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000012043 crude product Substances 0.000 claims description 27
- 238000000746 purification Methods 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 17
- 238000007710 freezing Methods 0.000 claims description 13
- 230000008014 freezing Effects 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 4
- 238000003379 elimination reaction Methods 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims 1
- 239000012535 impurity Substances 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000001953 recrystallisation Methods 0.000 abstract description 3
- 238000004440 column chromatography Methods 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 34
- 239000000047 product Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000001291 vacuum drying Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000003480 eluent Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- AWJUIBRHMBBTKR-UHFFFAOYSA-N iso-quinoline Natural products C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012913 prioritisation Methods 0.000 description 1
- 239000003590 rho kinase inhibitor Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910184597 CN102002036B (zh) | 2009-08-31 | 2009-08-31 | 一种法舒地尔的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910184597 CN102002036B (zh) | 2009-08-31 | 2009-08-31 | 一种法舒地尔的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102002036A CN102002036A (zh) | 2011-04-06 |
CN102002036B true CN102002036B (zh) | 2013-01-30 |
Family
ID=43809769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910184597 Active CN102002036B (zh) | 2009-08-31 | 2009-08-31 | 一种法舒地尔的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102002036B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103509002B (zh) * | 2012-06-20 | 2015-05-13 | 徐州万邦金桥制药有限公司 | 一种盐酸法舒地尔的纯化脱色方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942505A (en) * | 1995-07-03 | 1999-08-24 | Asahi Kasei Kogyo Kabushiki Kaisha | 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrates |
CN101092413A (zh) * | 2006-06-23 | 2007-12-26 | 黄振华 | 法舒地尔的药用盐的水合物 |
-
2009
- 2009-08-31 CN CN 200910184597 patent/CN102002036B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942505A (en) * | 1995-07-03 | 1999-08-24 | Asahi Kasei Kogyo Kabushiki Kaisha | 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrates |
CN101092413A (zh) * | 2006-06-23 | 2007-12-26 | 黄振华 | 法舒地尔的药用盐的水合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102002036A (zh) | 2011-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101830852B (zh) | 一种新路线的依达拉奉化合物 | |
JP5085546B2 (ja) | 濃縮イソプレゴールの調製方法 | |
WO2006092617A1 (en) | Crystallisation and purification of glycopyrronium bromide | |
CN105061328A (zh) | 一种奥拉帕尼的精制方法 | |
CN110372610A (zh) | 一种5-氟尿嘧啶的组合物及其精制方法 | |
CN102351847B (zh) | 一种工业化的埃索美拉唑钠盐的精制方法 | |
CN102002036B (zh) | 一种法舒地尔的精制方法 | |
CN102584626B (zh) | 一种乙氧基亚甲基丙二腈的合成方法 | |
CN113710655B (zh) | 氟哌啶醇的纯化方法 | |
EP2236510B1 (en) | Process for isolation of a mixture of rrrs and sssr configurations of nebivolol intermediates | |
CN102603627A (zh) | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物及其制备方法 | |
CN107033114B (zh) | 一种二氢杨梅素的分离纯化方法 | |
CN102219816A (zh) | 一种罗红霉素的纯化方法 | |
CN101735220A (zh) | 一种6,7-二氢-6-巯基-5H-吡唑[1,2-a][1,2,4]三唑内鎓氯化物的晶型及其制备方法 | |
CN102702203B (zh) | 一种美罗培南的精制方法 | |
CN107903241A (zh) | 硫酸乙烯酯的提纯方法 | |
CN102503853A (zh) | 一种二苯甲酮腙的合成方法 | |
CN1803773A (zh) | 氟尼辛葡甲胺的合成提取精制方法 | |
CN105439892B (zh) | 一种赖诺普利氢化物的精制方法 | |
CN109608398A (zh) | 一种依达拉奉的制备方法 | |
CN101891745B (zh) | 亚胺培南一水合物晶体的制备方法 | |
CN104557857A (zh) | 一种泊利度胺的纯化方法 | |
CN107382882A (zh) | 一种氯法齐明的精制方法 | |
CN110294739A (zh) | 一种氯虫苯甲酰胺的纯化方法 | |
CN102993145B (zh) | 一种提取纯化洛伐他汀的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU CAREFREE MEDICINE CO., LTD. Free format text: FORMER OWNER: QIN YINLIN Effective date: 20131126 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131126 Address after: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee after: JIANGSU CAREPHAR PHARMACEUTICAL CO., LTD. Address before: 210016 Jiangsu Province, Nanjing city Zhongshan Road No. 323, 2 (former banshanyuan No. 12 Building 1 layer 1) Patentee before: Qin Yinlin |